A Challenging Case of Severe Infantile Cholestasis in Alpha-1 Antitrypsin Deficiency

Abstract

Jaundice in the newborn period can be physiologic and is often due to benign causes. Jaundice due to conjugated hyperbilirubinemia extending beyond the second week of life may be an early sign of several cholestatic or metabolic liver diseases, and it requires logical and timely analysis so that specific treatments can be initiated. Alpha-1 antitrypsin deficiency is the most common genetic cause of pediatric liver disease and transplantation, and it must be considered when evaluating cholestatic infants. Here, we present an unusual case of alpha-1 antitrypsin deficiency with severe infantile cholestasis and rapid decompensation in the first 4 months of life, where in-depth but timely diagnosis was crucial for the appropriate intervention to take place.

Keywords

alpha-1 antitrypsin deficiency neonatal cholestasis liver transplantation hyperbilirubinemia cirrhosis metabolic disease

Get full access to this article

View all access options for this article.

References

Serinet

Wildhaber

Broue

. Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening. Pediatrics 2009; 123(5): 1280–1286.

Schreiber

Barker

Roberts

. Biliary atresia: the Canadian experience. J Pediatr 2007; 151(6): 659–665.

Yokoyama

Mizuta

. Stool color card screening for early detection of biliary atresia and long-term native liver survival: a 19-year cohort study in Japan. J Pediatr 2015; 166(4): 897–902.

Mogul

Zhou

Intihar

Schwarz

Frick

. Cost-effective analysis of screening for biliary atresia with the stool color card. J Pediatr Gastroenterol Nutr 2015; 60(1): 91–98.

Franciscovich

Vaidya

Doyle

. PoopMD, a mobile health application, accurately identifies infant acholic stools. PLoS One 2015; 10(7): e0132270.

Teckman

Pardee

Howell

. Appropriateness of newborn screening for alpha1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr 2014; 58(2): 199–203.

Talbot

Mowat

. Liver disease in infancy: histological features and relationship to alpha-antitrypsin phenotype. J Clin Pathol 1975; 28(7): 559–563.

Chu AS, Chopra KB, Perlmutter DH. Is severe progressive liver disease caused by alpha-1-antitrypsin deficiency more common in children or adults? Liver Transpl. 2016;22(7):886–894.

Aagenaes

TFagerhol

Elgjo

Munthe

Hovig

. Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals. Postgrad Med J 1974; 50(584): 365–375.

10.

McPhie

Binnie

Brunt

. Alpha 1-antitrypsin deficiency and infantile liver disease. Arch Dis Child 1976; 51(8): 584–588.

11.

Pferdmenges

Baumann

Muller-Heine

Framke

Pfister

. Prognostic marker for liver disease due to alpha1-antitrypsin deficiency. Klin Padiatr 2013; 225(5): 257–262.

12.

Arias

Kerner

Christofferson

Berquist

Park

. Misdiagnosis of alpha-1 antitrypsin phenotype in an infant with CMV infection and liver failure. Dig Dis Sci 2014; 59(8): 1710–1713.

13.

Potocnjak

Tesovic

Kuna

Stefanovic

Zaja

. Unusually difficult clinical presentation of an infant suffering from congenital Cytomegalovirus (CMV) infection combined with alpha 1-antitrypsin (A1AT) deficiency. Biochem Med (Zagreb) 2014; 24(3): 396–402.

14.

Ghouse

Chu

Wang

Perlmutter

. Mysteries of alpha1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease. Dis Model Mech 2014; 7(4): 411–419.

15.

Khan Z. Pathogenesis of alpha-1 antitrypsin deficiency in the liver: New approaches to old questions. J Liver Res Disord Ther. 2016;2(2):00023.

16.

Piitulainen

Carlson

Ohlsson

Sveger

. Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease/protease inhibitor studies. Chest 2005; 128(4): 2076–2081.

17.

Sveger

. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976; 294(24): 1316–1321.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB